Inventor · disambiguated record
Francois Rougeon
Also filed as: ROUGEON FRANCOIS · ROUGEON FRANÇOIS
15 granted patents·7 pending applications·214 citations·filing 1992–2017
94Inventor score
Top patents by PatentIndex Score
22 records- 0191US8460888B2Variable domains of camelid heavy-chain antibodies directed against glial fibrillary acidic proteinsLAFAYE PIERRE·Filed 2009·Granted Jun 11, 2013·38 cites·22 claims
- 0288US7625713B2Process for identifying a ligand that binds to the NEP binding site for the SMR1 pentapeptidePASTEUR INSTITUT·Filed 2006·Granted Dec 1, 2009·10 cites·5 claims
- 0383US7153833B2Therapeutic uses of SMR1 peptidesCENTRE NAT RECH SCIENT·Filed 2001·Granted Dec 26, 2006·14 cites·35 claims
- 0480US7423020B2Treatment of mood disorders by administration of SMR1PASTEUR INSTITUT·Filed 2001·Granted Sep 9, 2008·10 cites·5 claims
- 0580US6025143AAntibodies directed against peptides derived from the SMR1 polypeptidePASTEUR INSTITUT·Filed 1995·Granted Feb 15, 2000·30 cites·11 claims
- 0676US7387778B2Therapeutic methods and compositions for the treatment of impaired interpersonal and behavioral disordersPASTEUR INSTITUT·Filed 2001·Granted Jun 17, 2008·9 cites·14 claims
- 0775US6589750B2Therapeutic use of the SMR1 protein, the SMR1 maturation products, specifically the QHNPR pentapeptide as well as its biologically active derivativesPASTEUR INSTITUT·Filed 1997·Granted Jul 8, 2003·32 cites·6 claims
- 0873US10155054B2Variable domains of camelid heavy-chain antibodies directed against glial fibrillary acidic proteinsPASTEUR INSTITUT·Filed 2017·Granted Dec 18, 2018·1 cites·14 claims
- 0967US2010041072A1Process for identifying a ligand that binds to the nep binding site for the smr1 pentapeptidePASTEUR INSTITUT·Filed 2009·Application pending·0 cites
- 1065US9387260B2VHH antibodies used as peptide vectors for delivering a substance of interestROUGEON FRANÇOIS·Filed 2009·Granted Jul 12, 2016·1 cites·27 claims
- 1164US6818405B2Therapeutic use of the SMR1 protein and active derivatives thereofPASTEUR INSTITUT·Filed 1998·Granted Nov 16, 2004·15 cites·57 claims
- 1264US2005153374A1Peptides and polypeptides derived from the submaxillary gland of the rat, corresponding polyclonal and monoclonal antibodies, corresponding hybridomas and uses of these products for diagnosis, for detection or therapeutic purposesPASTEUR INSTITUT·Filed 2004·Application pending·0 cites
- 1363US5859189APeptides and polypeptides derived from the submaxillary gland of the rat, corresponding polyclonal and monoclonal antibodies, corresponding hybridomas and uses of these products for diagnosis, for detection or therapeutic purposesPASTEUR INSTITUT·Filed 1993·Granted Jan 12, 1999·18 cites·9 claims
- 1458US7429448B2Therapeutic use of the SMR1 protein and active derivatives thereofPASTEUR INSTITUT·Filed 2003·Granted Sep 30, 2008·10 cites·28 claims
- 1553US2014206081A1Variable domains of camelid heavy-chain antibodies directed against glial fibrillary acidic proteinsPASTEUR INSTITUT·Filed 2013·Application pending·0 cites
- 1651US5756323AMethod for generating structural and functional diversity in a peptide sequencePASTEUR INSTITUT·Filed 1992·Granted May 26, 1998·17 cites·20 claims
- 1750US2003186870A1Therapeutic methods and compositions for the treatment of impaired interpersonal and behavioral disordersFiled 2002·Application pending·0 cites
- 1849US10174105B2Use of VHH antibodies for the preparation of peptide vectors for delivering a substance of interest and their applicationsPASTEUR INSTITUT·Filed 2016·Granted Jan 8, 2019·0 cites·10 claims
- 1949US2010266576A1Use of a camelid single-domain antibody for detecting an oligomeric form of an amyloid beta peptide and its applicationsCENTRE NAT RECH SCIENT·Filed 2008·Application pending·0 cites
- 2047US6916607B2Peptides and polypeptides derived from the submaxillary gland of the rat corresponding polyclonal and monoclonal antibodies corresponding hybridomas and uses of these products for diagnosis for detection or therapeutic purposesPASTEUR INSTITUT·Filed 1999·Granted Jul 12, 2005·9 cites·2 claims
- 2143US2013165347A1Use of terminal deoxynucleotidyl transferase for mutagenic dna repair to generate variability, at a determined position in dnaROUGEON FRANCOIS·Filed 2011·Application pending·0 cites
- 2232US2003195155A1Therapeutic use of the SMR1 protein, the SMR1 maturation products, specifically the QHNPR pentapeptide as well as its biologically active derivativesPASTEUR INSTITUT·Filed 2003·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Francois Rougeon files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →